Modulight Biotherapeutics
PrivateLast Round
Seed
Nov 12, 2025
Total Funding Raised
$12.2M
Company Overview
Modulight Biotherapeutics is a biotechnology company developing a precision neuromodulation platform using optogenetics to treat severe neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Modulight Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
Modulight Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 12, 2025 |
Key People
Founding team and executive leadership
Modulight Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Fresh.Fund | Seed |
| Jibe Ventures | Seed |
| Nexus NeuroTech Ventures | Seed |
| Secret Chord Ventures | Seed |
| SilverArc Capital Management | Seed |
| LocalGlobe | Seed |
Modulight Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Modulight Biotherapeutics's valuation, stock price, and market status.
